Skip to content

Clinical trials

Phase 2 Glioblastoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20041
20091
20111
20121
20131
20142
20152
20171
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Novartis Pharmaceuticals2
AbbVie1
Eli Lilly and Company1
Incyte Corporation1
Insel Gruppe AG, University Hospital Bern1
Karyopharm Therapeutics Inc1
Rigel Pharmaceuticals1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma15
Brain Neoplasms7
Central Nervous System Neoplasms7
Glioma6
Oligodendroglioma6
Astrocytoma5
Gliosarcoma5
Diffuse Intrinsic Pontine Glioma1
Ganglioglioma1
Ganglioneuroma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.